Skip to main content
. 2017 Jan 16;58(2):401–406. doi: 10.3349/ymj.2017.58.2.401

Table 3. Comparison of Levels of Serum and Urine Nephrin between Normal and Subsequent PE Patients.

Control (n=68) PE (n=12) p value*
Serum nephrin (ng/mL)
 <15 wks 82.91 (39.90–189.50) 80.48 (55.71–108.99) 0.80
 16–20 wks 84.08 (27.79–225.60) 88.35 (69.25–200.30) 0.20
 21–28 wks 73.15 (21.57–226.92) 145.64 (58.68–210.42) <0.001
 29–40 wks 70.00 (18.07–142.66) 100.60 (73.30–131.41) <0.001
Urine nephrin (ng/mL)
 <15 wks 0.08 (0.01–1.03) 0.10 (0.01–0.30) 0.49
 16–20 wks 0.11 (0.01–0.85) 0.26 (0.10–0.53) 0.33
 21–28 wks 0.17 (0.01–1.03) 0.23 (0.09–0.99) 0.78
 29–40 wks 0.19 (0.01–1.17) 2.11 (0.85–2.86) <0.001

PE, preeclampsia.

Values are expressed as median (range).

*p-value by Mann-Whitney U test.